Next Article in Journal
Field Verification of an African Swine Fever Virus Loop-Mediated Isothermal Amplification (LAMP) Assay during an Outbreak in Timor-Leste
Previous Article in Journal
Discovery of Surfactant-Like Peptides from a Phage-Displayed Peptide Library
Previous Article in Special Issue
Multiplexed tat-Targeting CRISPR-Cas9 Protects T Cells from Acute HIV-1 Infection with Inhibition of Viral Escape
Open AccessReview

Block-And-Lock: New Horizons for a Cure for HIV-1

Department of Immunology and Microbiology, The Scripps Research Institute, 130 Scripps Way, Jupiter, FL 33458, USA
*
Author to whom correspondence should be addressed.
Academic Editor: Boris Matija Peterlin
Viruses 2020, 12(12), 1443; https://doi.org/10.3390/v12121443
Received: 7 October 2020 / Revised: 1 December 2020 / Accepted: 8 December 2020 / Published: 15 December 2020
(This article belongs to the Special Issue Antiretroviral Drug Development and HIV Cure Research)
HIV-1/AIDS remains a global public health problem. The world health organization (WHO) reported at the end of 2019 that 38 million people were living with HIV-1 worldwide, of which only 67% were accessing antiretroviral therapy (ART). Despite great success in the clinical management of HIV-1 infection, ART does not eliminate the virus from the host genome. Instead, HIV-1 remains latent as a viral reservoir in any tissue containing resting memory CD4+ T cells. The elimination of these residual proviruses that can reseed full-blown infection upon treatment interruption remains the major barrier towards curing HIV-1. Novel approaches have recently been developed to excise or disrupt the virus from the host cells (e.g., gene editing with the CRISPR-Cas system) to permanently shut off transcription of the virus (block-and-lock and RNA interference strategies), or to reactivate the virus from cell reservoirs so that it can be eliminated by the immune system or cytopathic effects (shock-and-kill strategy). Here, we will review each of these approaches, with the major focus placed on the block-and-lock strategy. View Full-Text
Keywords: antiretroviral therapy; HIV-1 latency; HIV-1 reservoir; functional cure; block-and-lock antiretroviral therapy; HIV-1 latency; HIV-1 reservoir; functional cure; block-and-lock
Show Figures

Figure 1

MDPI and ACS Style

Moranguinho, I.; Valente, S.T. Block-And-Lock: New Horizons for a Cure for HIV-1. Viruses 2020, 12, 1443. https://doi.org/10.3390/v12121443

AMA Style

Moranguinho I, Valente ST. Block-And-Lock: New Horizons for a Cure for HIV-1. Viruses. 2020; 12(12):1443. https://doi.org/10.3390/v12121443

Chicago/Turabian Style

Moranguinho, Ines; Valente, Susana T. 2020. "Block-And-Lock: New Horizons for a Cure for HIV-1" Viruses 12, no. 12: 1443. https://doi.org/10.3390/v12121443

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop